Latest filing published 02 Mar 2026 for ANI Pharmaceuticals INC, €726k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Muthusamy Shanmugam: trading record in brief
Muthusamy Shanmugam is a declared insider of ANI Pharmaceuticals Inc (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 19 November 2021 to 26 February 2026, the count stands at 80 filings.
Market trades split into 2 purchases (€251k) and 67 sales (€57.2M). On balance, insiders were net sellers of €57.0M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 11 share grants.
Most recently, on 2 March 2026, the filings show a share grant worth €726k in ANI Pharmaceuticals Inc. The most recent open-market purchase was published on 21 March 2022, 1,693 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Muthusamy Shanmugam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,116 shares@ US$77.152.3% of flowCommon StockSEC:0001870913-26-000005:0
- 2,898 shares@ US$76.250.6% of flowCommon StockSEC:0001870913-26-000002:0
- 47,012 shares@ US$90.2711.7% of flowCommon StockSEC:0001870913-25-000008:0
- 47,010 shares@ US$89.4813.1% of flowCommon StockSEC:0001870913-25-000006:0
- 700 shares@ US$76.830.2% of flowCommon StockSEC:0001870913-25-000004:0
- 14,362 shares0Common StockSEC:0001870913-25-000002:0
- 9,574 shares0Common StockSEC:0001870913-25-000002:1
- 2,743 shares@ US$62.000.7% of flowCommon StockSEC:0001870913-24-000028:0
- 11,000 shares@ US$63.382.7% of flowCommon StockSEC:0001870913-24-000026:0
- 20,000 shares@ US$58.904.6% of flowCommon StockSEC:0001870913-24-000024:0
- 7,946 shares@ US$61.411.9% of flowCommon StockSEC:0001870913-24-000022:0
- 12,855 shares@ US$61.813.0% of flowCommon StockSEC:0001870913-24-000020:0
- 14,850 shares@ US$65.863.7% of flowCommon StockSEC:0001870913-24-000018:0
- 10,423 shares@ US$64.982.7% of flowCommon StockSEC:0001870913-24-000016:0
- 7,414 shares@ US$66.331.9% of flowCommon StockSEC:0001870913-24-000014:0
- 10,000 shares@ US$67.172.6% of flowCommon StockSEC:0001870913-24-000012:0
- 10,093 shares@ US$65.352.5% of flowCommon StockSEC:0001870913-24-000010:0
- 1,122 shares@ US$67.670.3% of flowCommon StockSEC:0001870913-24-000008:0
- 13,421 shares0Common StockSEC:0001870913-24-000006:0
- 4,524 shares@ US$55.571.0% of flowCommon StockSEC:0001870913-24-000004:0
- 5,692 shares@ US$55.951.2% of flowCommon StockSEC:0001870913-24-000004:1
- 15,000 shares@ US$56.443.2% of flowCommon StockSEC:0001870913-24-000004:2
- 5,000 shares@ US$55.631.1% of flowCommon StockSEC:0001870913-24-000002:0
- 11,974 shares@ US$52.442.4% of flowCommon StockSEC:0001870913-23-000020:0
- 13,026 shares@ US$52.442.6% of flowCommon StockSEC:0001870913-23-000020:1
25 of 47 declarations
